Johnson & Johnson announced plans to separate its Orthopaedics business to establish a standalone Orthopaedics company, operating as DePuy Synthes. The process of the planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements, including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals. Should you accept this position, it is anticipated that, following conclusion of the transaction, you would be an employee of DePuy Synthes, and your employment would be governed by DePuy Synthes employment processes, programs, policies, and benefit plans. In that case, details of any planned changes would be provided to you by DePuy Synthes at an appropriate time and subject to any necessary consultation processes. DePuy Synthes is a global leader in Orthopaedics, advancing patient care through innovative solutions across joint reconstruction, trauma, spine, sports medicine, and related surgical technologies. As DePuy Synthes separates from Johnson & Johnson to become the world’s largest, most comprehensive Orthopaedics-focused company, the organization is entering a defining chapter—establishing its own corporate identity, voice, culture, and reputation while continuing to serve patients, customers, and healthcare systems around the world. The Chief Compliance Officer Depuy Synthes will lead the global health care compliance team and the global Depuy Synthes compliance program, reporting to the Chief Operations Officer of Depuy Synthes. The Chief Compliance Officer will lead the establishment and development of strategy, long-term planning and policies of health care compliance programs. This leader will ensure that the business understands and complies with applicable laws and regulations pertaining to the health care environment. The leader will drive business accountability for compliance by overseeing, follow-up and resolution of investigations. The leader will also report to the Global leadership team and to the Board of Directors of Depuy Synthes if, and when the company becomes a publicly traded company. The Chief Compliance Officer Depuy Synthes serves as a key member of the senior leadership, with enterprise-wide responsibility for the design, oversight, and effectiveness of the Health Care Compliance program. The role provides independent, objective compliance leadership and is accountable for setting global compliance strategy and strategic direction that enables the business to achieve its objectives while operating in accordance with applicable laws, regulations, and ethical standards across diverse markets and risk environments. The Chief Compliance Officer Depuy Synthes represents the organization externally with regulators, enforcement authorities, and industry groups, helping to shape industry standards and compliance expectations, and serving as a visible leader in advancing ethical business practices. Internally, the role ensures the independence, authority, and visibility of the compliance function, resolution of investigations; reinforces the message that compliance and integrity are core company priorities; and coordinates the resources, governance, and infrastructure required to implement and sustain an effective compliance program across business units and geographies. In this capacity, the Chief Compliance Officer serves as a trusted advisor to senior management and the Board (or Board-level committee, if and when it becomes publicly traded company) on compliance, ethics, and risk matters, providing insight on emerging risks, regulatory trends, and mitigation strategies. The role is responsible for fostering a strong culture of compliance, driving accountability, and ensuring consistent, scalable program execution across regions with varying regulatory complexity, corruption risk, and maturity.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Number of Employees
5,001-10,000 employees